Search

Your search keyword '"Dzintars Gotham"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Dzintars Gotham" Remove constraint Author: "Dzintars Gotham"
43 results on '"Dzintars Gotham"'

Search Results

1. Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.

3. Public investments in the development of GeneXpert molecular diagnostic technology.

4. Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries

5. Public investments in the clinical development of bedaquiline.

6. Global health research and education at medical faculties in Germany.

7. Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

8. Quantifying changes in global health inequality: the Gini and Slope Inequality Indices applied to the Global Burden of Disease data, 1990–2017

9. Cell line access to revolutionize the biosimilars market [version 1; referees: 2 approved]

10. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

11. Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

14. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

15. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

16. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

17. Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials

18. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

19. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

20. Variation in the prices of oncology medicines across Europe and the implications for the future

21. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

22. Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries

23. Public investments in the clinical development of bedaquiline

24. Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States

25. Candidates for inclusion in a universal antiretroviral regimen

26. Quantifying changes in global health inequality: the Gini and Slope Inequality Indices applied to the Global Burden of Disease data, 1990–2017

27. Pricing of oral generic cancer medicines in 25 European countries; findings and implications

28. Patent pooling to increase access to essential medicines

29. How a US-UK trade agreement could affect NHS drug prices

30. Estimated costs of production and potential prices for the WHO Essential Medicines List

31. Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries

32. Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

33. Potential price reductions for cancer medicines on the WHO Essential Medicines List

34. Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List

35. Estimated generic prices for novel treatments for drug resistant tuberculosis

36. Production costs and potential prices for biosimilars of human insulin and insulin analogues

37. Drug prices threaten the NHS

38. Generic treatments for human immunodeficiency virus, hepatitis B virus, hepatitis C virus, TB could be mass-produced for <$90 per patient

39. Significant Reductions in Costs of Generic Production of Sofosbuvir and Daclatasvir for Hepatitis C Treatment in Low- and Middle-Income Countries

40. Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

42. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

43. Global health equity in United Kingdom university research: a landscape of current policies and practices

Catalog

Books, media, physical & digital resources